 | • レポートコード：QYR2104Z4390 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、オキサリプラチンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（マンニトール、ブドウ糖液、乳糖液、その他）、用途別市場規模（結腸直腸がん、胃がん、卵巣がん、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・オキサリプラチンの市場動向 ・企業の競争状況、市場シェア ・オキサリプラチンの種類別市場規模（マンニトール、ブドウ糖液、乳糖液、その他） ・オキサリプラチンの用途別市場規模（結腸直腸がん、胃がん、卵巣がん、その他） ・オキサリプラチンの北米市場規模2016-2027（アメリカ、カナダ） ・オキサリプラチンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・オキサリプラチンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・オキサリプラチンの中南米市場規模2016-2027（メキシコ、ブラジル） ・オキサリプラチンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sanofi-Aventis、Yakult honsha、Dr Reddy's laboratories、Sun Pharmaceutical、Teva、Fresenius Kabi、Hospira、Mylan、Jiangsu Hengrui Medicine、Nanjing Pharmaceutical Factory、Jiangsu Aosaikang Pharmaceutical、Qilu Pharmaceutical、Hisun Pharmaceutical、Lunan Pharmaceutical、Luoxin、Halfsky Pharmacy、YRPG、Hainan Jinrui Pharmaceutical、Jari Pharmaceutical、Chiatai Tianqing） ・結論 |
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.
In this report, only the finished drug is covered, exclude API.
The Oxaliplatin concentration is high; there are many manufacturers in the world, and high-end products mainly from USA and Europe. In the world wide, giant manufactures mainly distribute in US, Europe and China such as Sanofi-Aventis, Yakult honsha, Dr Reddy’s laboratories, Teva and Jiangsu Hengrui Medicine.
Market Analysis and Insights: Global Oxaliplatin Market
The global Oxaliplatin market size is projected to reach US$ 976.5 million by 2026, from US$ 848.8 million in 2019, at a CAGR of 2.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oxaliplatin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oxaliplatin market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oxaliplatin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oxaliplatin market.
Global Oxaliplatin Scope and Market Size
Oxaliplatin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oxaliplatin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Mannitol
Glucose Solution
Lactose Solution
Other
Segment by Application
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Sanofi-Aventis
Yakult honsha
Dr Reddy’s laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira
Mylan
Jiangsu Hengrui Medicine
Sun Pharmaceutical
Teva
Qilu Pharmaceutical
Hisun Pharmaceutical
Lunan Pharmaceutical
Luoxin
Halfsky Pharmacy
YRPG
Hainan Jinrui Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oxaliplatin Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mannitol
1.2.3 Glucose Solution
1.2.4 Lactose Solution
1.2.5 Other
1.3 Market by Application
1.3.1 Global Oxaliplatin Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Colorectal Cancer
1.3.3 Stomach Cancer
1.3.4 Ovarian Cancer
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oxaliplatin Market Perspective (2016-2027)
2.2 Oxaliplatin Growth Trends by Regions
2.2.1 Oxaliplatin Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oxaliplatin Historic Market Share by Regions (2016-2021)
2.2.3 Oxaliplatin Forecasted Market Size by Regions (2022-2027)
2.3 Oxaliplatin Industry Dynamic
2.3.1 Oxaliplatin Market Trends
2.3.2 Oxaliplatin Market Drivers
2.3.3 Oxaliplatin Market Challenges
2.3.4 Oxaliplatin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oxaliplatin Players by Revenue
3.1.1 Global Top Oxaliplatin Players by Revenue (2016-2021)
3.1.2 Global Oxaliplatin Revenue Market Share by Players (2016-2021)
3.2 Global Oxaliplatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oxaliplatin Revenue
3.4 Global Oxaliplatin Market Concentration Ratio
3.4.1 Global Oxaliplatin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oxaliplatin Revenue in 2020
3.5 Oxaliplatin Key Players Head office and Area Served
3.6 Key Players Oxaliplatin Product Solution and Service
3.7 Date of Enter into Oxaliplatin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oxaliplatin Breakdown Data by Type
4.1 Global Oxaliplatin Historic Market Size by Type (2016-2021)
4.2 Global Oxaliplatin Forecasted Market Size by Type (2022-2027)
5 Oxaliplatin Breakdown Data by Application
5.1 Global Oxaliplatin Historic Market Size by Application (2016-2021)
5.2 Global Oxaliplatin Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Oxaliplatin Market Size (2016-2027)
6.2 North America Oxaliplatin Market Size by Type
6.2.1 North America Oxaliplatin Market Size by Type (2016-2021)
6.2.2 North America Oxaliplatin Market Size by Type (2022-2027)
6.2.3 North America Oxaliplatin Market Size by Type (2016-2027)
6.3 North America Oxaliplatin Market Size by Application
6.3.1 North America Oxaliplatin Market Size by Application (2016-2021)
6.3.2 North America Oxaliplatin Market Size by Application (2022-2027)
6.3.3 North America Oxaliplatin Market Size by Application (2016-2027)
6.4 North America Oxaliplatin Market Size by Country
6.4.1 North America Oxaliplatin Market Size by Country (2016-2021)
6.4.2 North America Oxaliplatin Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Oxaliplatin Market Size (2016-2027)
7.2 Europe Oxaliplatin Market Size by Type
7.2.1 Europe Oxaliplatin Market Size by Type (2016-2021)
7.2.2 Europe Oxaliplatin Market Size by Type (2022-2027)
7.2.3 Europe Oxaliplatin Market Size by Type (2016-2027)
7.3 Europe Oxaliplatin Market Size by Application
7.3.1 Europe Oxaliplatin Market Size by Application (2016-2021)
7.3.2 Europe Oxaliplatin Market Size by Application (2022-2027)
7.3.3 Europe Oxaliplatin Market Size by Application (2016-2027)
7.4 Europe Oxaliplatin Market Size by Country
7.4.1 Europe Oxaliplatin Market Size by Country (2016-2021)
7.4.2 Europe Oxaliplatin Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Oxaliplatin Market Size (2016-2027)
8.2 Asia-Pacific Oxaliplatin Market Size by Type
8.2.1 Asia-Pacific Oxaliplatin Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oxaliplatin Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oxaliplatin Market Size by Type (2016-2027)
8.3 Asia-Pacific Oxaliplatin Market Size by Application
8.3.1 Asia-Pacific Oxaliplatin Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oxaliplatin Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oxaliplatin Market Size by Application (2016-2027)
8.4 Asia-Pacific Oxaliplatin Market Size by Region
8.4.1 Asia-Pacific Oxaliplatin Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oxaliplatin Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oxaliplatin Market Size (2016-2027)
9.2 Latin America Oxaliplatin Market Size by Type
9.2.1 Latin America Oxaliplatin Market Size by Type (2016-2021)
9.2.2 Latin America Oxaliplatin Market Size by Type (2022-2027)
9.2.3 Latin America Oxaliplatin Market Size by Type (2016-2027)
9.3 Latin America Oxaliplatin Market Size by Application
9.3.1 Latin America Oxaliplatin Market Size by Application (2016-2021)
9.3.2 Latin America Oxaliplatin Market Size by Application (2022-2027)
9.3.3 Latin America Oxaliplatin Market Size by Application (2016-2027)
9.4 Latin America Oxaliplatin Market Size by Country
9.4.1 Latin America Oxaliplatin Market Size by Country (2016-2021)
9.4.2 Latin America Oxaliplatin Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oxaliplatin Market Size (2016-2027)
10.2 Middle East & Africa Oxaliplatin Market Size by Type
10.2.1 Middle East & Africa Oxaliplatin Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oxaliplatin Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oxaliplatin Market Size by Type (2016-2027)
10.3 Middle East & Africa Oxaliplatin Market Size by Application
10.3.1 Middle East & Africa Oxaliplatin Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oxaliplatin Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oxaliplatin Market Size by Application (2016-2027)
10.4 Middle East & Africa Oxaliplatin Market Size by Country
10.4.1 Middle East & Africa Oxaliplatin Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oxaliplatin Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi-Aventis
11.1.1 Sanofi-Aventis Company Details
11.1.2 Sanofi-Aventis Business Overview
11.1.3 Sanofi-Aventis Oxaliplatin Introduction
11.1.4 Sanofi-Aventis Revenue in Oxaliplatin Business (2016-2021)
11.1.5 Sanofi-Aventis Recent Development
11.2 Yakult honsha
11.2.1 Yakult honsha Company Details
11.2.2 Yakult honsha Business Overview
11.2.3 Yakult honsha Oxaliplatin Introduction
11.2.4 Yakult honsha Revenue in Oxaliplatin Business (2016-2021)
11.2.5 Yakult honsha Recent Development
11.3 Dr Reddy’s laboratories
11.3.1 Dr Reddy’s laboratories Company Details
11.3.2 Dr Reddy’s laboratories Business Overview
11.3.3 Dr Reddy’s laboratories Oxaliplatin Introduction
11.3.4 Dr Reddy’s laboratories Revenue in Oxaliplatin Business (2016-2021)
11.3.5 Dr Reddy’s laboratories Recent Development
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Details
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Oxaliplatin Introduction
11.4.4 Sun Pharmaceutical Revenue in Oxaliplatin Business (2016-2021)
11.4.5 Sun Pharmaceutical Recent Development
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva Oxaliplatin Introduction
11.5.4 Teva Revenue in Oxaliplatin Business (2016-2021)
11.5.5 Teva Recent Development
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Details
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Oxaliplatin Introduction
11.6.4 Fresenius Kabi Revenue in Oxaliplatin Business (2016-2021)
11.6.5 Fresenius Kabi Recent Development
11.7 Hospira
11.7.1 Hospira Company Details
11.7.2 Hospira Business Overview
11.7.3 Hospira Oxaliplatin Introduction
11.7.4 Hospira Revenue in Oxaliplatin Business (2016-2021)
11.7.5 Hospira Recent Development
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Mylan Business Overview
11.8.3 Mylan Oxaliplatin Introduction
11.8.4 Mylan Revenue in Oxaliplatin Business (2016-2021)
11.8.5 Mylan Recent Development
11.9 Jiangsu Hengrui Medicine
11.9.1 Jiangsu Hengrui Medicine Company Details
11.9.2 Jiangsu Hengrui Medicine Business Overview
11.9.3 Jiangsu Hengrui Medicine Oxaliplatin Introduction
11.9.4 Jiangsu Hengrui Medicine Revenue in Oxaliplatin Business (2016-2021)
11.9.5 Jiangsu Hengrui Medicine Recent Development
11.10 Nanjing Pharmaceutical Factory
11.10.1 Nanjing Pharmaceutical Factory Company Details
11.10.2 Nanjing Pharmaceutical Factory Business Overview
11.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Introduction
11.10.4 Nanjing Pharmaceutical Factory Revenue in Oxaliplatin Business (2016-2021)
11.10.5 Nanjing Pharmaceutical Factory Recent Development
11.11 Jiangsu Aosaikang Pharmaceutical
11.11.1 Jiangsu Aosaikang Pharmaceutical Company Details
11.11.2 Jiangsu Aosaikang Pharmaceutical Business Overview
11.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Introduction
11.11.4 Jiangsu Aosaikang Pharmaceutical Revenue in Oxaliplatin Business (2016-2021)
11.11.5 Jiangsu Aosaikang Pharmaceutical Recent Development
11.12 Qilu Pharmaceutical
11.12.1 Qilu Pharmaceutical Company Details
11.12.2 Qilu Pharmaceutical Business Overview
11.12.3 Qilu Pharmaceutical Oxaliplatin Introduction
11.12.4 Qilu Pharmaceutical Revenue in Oxaliplatin Business (2016-2021)
11.12.5 Qilu Pharmaceutical Recent Development
11.13 Hisun Pharmaceutical
11.13.1 Hisun Pharmaceutical Company Details
11.13.2 Hisun Pharmaceutical Business Overview
11.13.3 Hisun Pharmaceutical Oxaliplatin Introduction
11.13.4 Hisun Pharmaceutical Revenue in Oxaliplatin Business (2016-2021)
11.13.5 Hisun Pharmaceutical Recent Development
11.14 Lunan Pharmaceutical
11.14.1 Lunan Pharmaceutical Company Details
11.14.2 Lunan Pharmaceutical Business Overview
11.14.3 Lunan Pharmaceutical Oxaliplatin Introduction
11.14.4 Lunan Pharmaceutical Revenue in Oxaliplatin Business (2016-2021)
11.14.5 Lunan Pharmaceutical Recent Development
11.15 Luoxin
11.15.1 Luoxin Company Details
11.15.2 Luoxin Business Overview
11.15.3 Luoxin Oxaliplatin Introduction
11.15.4 Luoxin Revenue in Oxaliplatin Business (2016-2021)
11.15.5 Luoxin Recent Development
11.16 Halfsky Pharmacy
11.16.1 Halfsky Pharmacy Company Details
11.16.2 Halfsky Pharmacy Business Overview
11.16.3 Halfsky Pharmacy Oxaliplatin Introduction
11.16.4 Halfsky Pharmacy Revenue in Oxaliplatin Business (2016-2021)
11.16.5 Halfsky Pharmacy Recent Development
11.17 YRPG
11.17.1 YRPG Company Details
11.17.2 YRPG Business Overview
11.17.3 YRPG Oxaliplatin Introduction
11.17.4 YRPG Revenue in Oxaliplatin Business (2016-2021)
11.17.5 YRPG Recent Development
11.18 Hainan Jinrui Pharmaceutical
11.18.1 Hainan Jinrui Pharmaceutical Company Details
11.18.2 Hainan Jinrui Pharmaceutical Business Overview
11.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Introduction
11.18.4 Hainan Jinrui Pharmaceutical Revenue in Oxaliplatin Business (2016-2021)
11.18.5 Hainan Jinrui Pharmaceutical Recent Development
11.18 Jari Pharmaceutical
.1 Jari Pharmaceutical Company Details
.2 Jari Pharmaceutical Business Overview
.3 Jari Pharmaceutical Oxaliplatin Introduction
.4 Jari Pharmaceutical Revenue in Oxaliplatin Business (2016-2021)
.5 Jari Pharmaceutical Recent Development
11.20 Chiatai Tianqing
11.20.1 Chiatai Tianqing Company Details
11.20.2 Chiatai Tianqing Business Overview
11.20.3 Chiatai Tianqing Oxaliplatin Introduction
11.20.4 Chiatai Tianqing Revenue in Oxaliplatin Business (2016-2021)
11.20.5 Chiatai Tianqing Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Oxaliplatin Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mannitol
Table 3. Key Players of Glucose Solution
Table 4. Key Players of Lactose Solution
Table 5. Key Players of Other
Table 6. Global Oxaliplatin Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Oxaliplatin Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Oxaliplatin Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Oxaliplatin Market Share by Regions (2016-2021)
Table 10. Global Oxaliplatin Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Oxaliplatin Market Share by Regions (2022-2027)
Table 12. Oxaliplatin Market Trends
Table 13. Oxaliplatin Market Drivers
Table 14. Oxaliplatin Market Challenges
Table 15. Oxaliplatin Market Restraints
Table 16. Global Oxaliplatin Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Oxaliplatin Market Share by Players (2016-2021)
Table 18. Global Top Oxaliplatin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxaliplatin as of 2020)
Table 19. Ranking of Global Top Oxaliplatin Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Oxaliplatin Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Oxaliplatin Product Solution and Service
Table 23. Date of Enter into Oxaliplatin Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oxaliplatin Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Oxaliplatin Revenue Market Share by Type (2016-2021)
Table 27. Global Oxaliplatin Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Oxaliplatin Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Oxaliplatin Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Oxaliplatin Revenue Market Share by Application (2016-2021)
Table 31. Global Oxaliplatin Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Oxaliplatin Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Oxaliplatin Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Oxaliplatin Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Oxaliplatin Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Oxaliplatin Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Oxaliplatin Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Oxaliplatin Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Oxaliplatin Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Oxaliplatin Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Oxaliplatin Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Oxaliplatin Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Oxaliplatin Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Oxaliplatin Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Oxaliplatin Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Oxaliplatin Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Oxaliplatin Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Oxaliplatin Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Oxaliplatin Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Oxaliplatin Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Oxaliplatin Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Oxaliplatin Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Oxaliplatin Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Oxaliplatin Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Oxaliplatin Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Oxaliplatin Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Oxaliplatin Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Oxaliplatin Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Oxaliplatin Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Oxaliplatin Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Oxaliplatin Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Oxaliplatin Market Size by Country (2022-2027) & (US$ Million)
Table 63. Sanofi-Aventis Company Details
Table 64. Sanofi-Aventis Business Overview
Table 65. Sanofi-Aventis Oxaliplatin Product
Table 66. Sanofi-Aventis Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 67. Sanofi-Aventis Recent Development
Table 68. Yakult honsha Company Details
Table 69. Yakult honsha Business Overview
Table 70. Yakult honsha Oxaliplatin Product
Table 71. Yakult honsha Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 72. Yakult honsha Recent Development
Table 73. Dr Reddy's laboratories Company Details
Table 74. Dr Reddy's laboratories Business Overview
Table 75. Dr Reddy's laboratories Oxaliplatin Product
Table 76. Dr Reddy's laboratories Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 77. Dr Reddy's laboratories Recent Development
Table 78. Sun Pharmaceutical Company Details
Table 79. Sun Pharmaceutical Business Overview
Table 80. Sun Pharmaceutical Oxaliplatin Product
Table 81. Sun Pharmaceutical Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 82. Sun Pharmaceutical Recent Development
Table 83. Teva Company Details
Table 84. Teva Business Overview
Table 85. Teva Oxaliplatin Product
Table 86. Teva Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 87. Teva Recent Development
Table 88. Fresenius Kabi Company Details
Table 89. Fresenius Kabi Business Overview
Table 90. Fresenius Kabi Oxaliplatin Product
Table 91. Fresenius Kabi Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 92. Fresenius Kabi Recent Development
Table 93. Hospira Company Details
Table 94. Hospira Business Overview
Table 95. Hospira Oxaliplatin Product
Table 96. Hospira Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 97. Hospira Recent Development
Table 98. Mylan Company Details
Table 99. Mylan Business Overview
Table 100. Mylan Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 101. Mylan Recent Development
Table 102. Jiangsu Hengrui Medicine Company Details
Table 103. Jiangsu Hengrui Medicine Business Overview
Table 104. Jiangsu Hengrui Medicine Oxaliplatin Product
Table 105. Jiangsu Hengrui Medicine Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 106. Jiangsu Hengrui Medicine Recent Development
Table 107. Nanjing Pharmaceutical Factory Company Details
Table 108. Nanjing Pharmaceutical Factory Business Overview
Table 109. Nanjing Pharmaceutical Factory Oxaliplatin Product
Table 110. Nanjing Pharmaceutical Factory Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 111. Nanjing Pharmaceutical Factory Recent Development
Table 112. Jiangsu Aosaikang Pharmaceutical Company Details
Table 113. Jiangsu Aosaikang Pharmaceutical Business Overview
Table 114. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product
Table 115. Jiangsu Aosaikang Pharmaceutical Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 116. Jiangsu Aosaikang Pharmaceutical Recent Development
Table 117. Qilu Pharmaceutical Company Details
Table 118. Qilu Pharmaceutical Business Overview
Table 119. Qilu Pharmaceutical Oxaliplatin Product
Table 120. Qilu Pharmaceutical Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 121. Qilu Pharmaceutical Recent Development
Table 122. Hisun Pharmaceutical Company Details
Table 123. Hisun Pharmaceutical Business Overview
Table 124. Hisun Pharmaceutical Oxaliplatin Product
Table 125. Hisun Pharmaceutical Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 126. Hisun Pharmaceutical Recent Development
Table 127. Lunan Pharmaceutical Company Details
Table 128. Lunan Pharmaceutical Business Overview
Table 129. Lunan Pharmaceutical Oxaliplatin Product
Table 130. Lunan Pharmaceutical Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 131. Lunan Pharmaceutical Recent Development
Table 132. Luoxin Company Details
Table 133. Luoxin Business Overview
Table 134. Luoxin Oxaliplatin Product
Table 135. Luoxin Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 136. Luoxin Recent Development
Table 137. Halfsky Pharmacy Company Details
Table 138. Halfsky Pharmacy Business Overview
Table 139. Halfsky Pharmacy Oxaliplatin Product
Table 140. Halfsky Pharmacy Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 141. Halfsky Pharmacy Recent Development
Table 142. YRPG Company Details
Table 143. YRPG Business Overview
Table 144. YRPG Oxaliplatin Product
Table 145. YRPG Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 146. YRPG Recent Development
Table 147. Hainan Jinrui Pharmaceutical Company Details
Table 148. Hainan Jinrui Pharmaceutical Business Overview
Table 149. Hainan Jinrui Pharmaceutical Oxaliplatin Product
Table 150. Hainan Jinrui Pharmaceutical Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 151. Hainan Jinrui Pharmaceutical Recent Development
Table 152. Jari Pharmaceutical Company Details
Table 153. Jari Pharmaceutical Business Overview
Table 154. Jari Pharmaceutical Oxaliplatin Product
Table 155. Jari Pharmaceutical Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 156. Jari Pharmaceutical Recent Development
Table 157. Chiatai Tianqing Company Details
Table 158. Chiatai Tianqing Business Overview
Table 159. Chiatai Tianqing Oxaliplatin Product
Table 160. Chiatai Tianqing Revenue in Oxaliplatin Business (2016-2021) & (US$ Million)
Table 161. Chiatai Tianqing Recent Development
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oxaliplatin Market Share by Type: 2020 VS 2027
Figure 2. Mannitol Features
Figure 3. Glucose Solution Features
Figure 4. Lactose Solution Features
Figure 5. Other Features
Figure 6. Global Oxaliplatin Market Share by Application: 2020 VS 2027
Figure 7. Colorectal Cancer Case Studies
Figure 8. Stomach Cancer Case Studies
Figure 9. Ovarian Cancer Case Studies
Figure 10. Other Case Studies
Figure 11. Oxaliplatin Report Years Considered
Figure 12. Global Oxaliplatin Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Oxaliplatin Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Oxaliplatin Market Share by Regions: 2020 VS 2027
Figure 15. Global Oxaliplatin Market Share by Regions (2022-2027)
Figure 16. Global Oxaliplatin Market Share by Players in 2020
Figure 17. Global Top Oxaliplatin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxaliplatin as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Oxaliplatin Revenue in 2020
Figure 19. Global Oxaliplatin Revenue Market Share by Type (2016-2021)
Figure 20. Global Oxaliplatin Revenue Market Share by Type (2022-2027)
Figure 21. North America Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Oxaliplatin Market Share by Type (2016-2027)
Figure 23. North America Oxaliplatin Market Share by Application (2016-2027)
Figure 24. North America Oxaliplatin Market Share by Country (2016-2027)
Figure 25. United States Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Oxaliplatin Market Share by Type (2016-2027)
Figure 29. Europe Oxaliplatin Market Share by Application (2016-2027)
Figure 30. Europe Oxaliplatin Market Share by Country (2016-2027)
Figure 31. Germany Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Oxaliplatin Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Oxaliplatin Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Oxaliplatin Market Share by Region (2016-2027)
Figure 41. China Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Oxaliplatin Market Share by Type (2016-2027)
Figure 49. Latin America Oxaliplatin Market Share by Application (2016-2027)
Figure 50. Latin America Oxaliplatin Market Share by Country (2016-2027)
Figure 51. Mexico Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Oxaliplatin Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Oxaliplatin Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Oxaliplatin Market Share by Country (2016-2027)
Figure 57. Turkey Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Oxaliplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Sanofi-Aventis Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 61. Yakult honsha Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 62. Dr Reddy's laboratories Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 63. Sun Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 64. Teva Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 65. Fresenius Kabi Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 66. Hospira Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 67. Mylan Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 68. Jiangsu Hengrui Medicine Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 69. Nanjing Pharmaceutical Factory Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 70. Jiangsu Aosaikang Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 71. Qilu Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 72. Hisun Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 73. Lunan Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 74. Luoxin Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 75. Halfsky Pharmacy Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 76. YRPG Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 77. Hainan Jinrui Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 78. Jari Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 79. Chiatai Tianqing Revenue Growth Rate in Oxaliplatin Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
世界のオキサリプラチン市場規模・現状・予測（2021年-2027年） Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely. In this report, only the finished drug is cove…- 世界の卵巣がん遺伝子治療市場規模・現状・予測（2021年-2027年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- 世界の卵巣がん市場規模・現状・予測（2021年-2027年） Ovarian cancer is a type of cancer that begins in the ovaries. Ovarian cancer is the most common type of cancer among women. Epithelial tumor, stromal tumor and germ cell tumors are the type of ovarian cancer. North America dominates the global market for ovarian cancer due to large number of aging …
- 世界の結腸直腸がん市場規模・現状・予測（2021年-2027年） Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). The major symptoms associated with colorectal cancer include diarrhea, constipation, blood in feces, pain in abdomen, loss of appetite, loss of …
- 世界の卵巣がん治療薬市場規模・現状・予測（2021年-2027年） Ovarian cancer, and its rising incidence rate, is a growing concern worldwide. Market players that are currently engaged in the development of drugs and therapies for ovarian cancer stand to benefit by observing the latest trends and pipeline competitor products. Market Analysis and Insights: Global…